Holding(s) in Company

AI SummaryClose X

On October 27, 2025, Fusion Antibodies PLC received notification that Maven Capital Partners UK LLP's voting rights in the company crossed a threshold on October 24, 2025. Maven Renovar VCT PLC, held 4,386,463 voting rights, representing 3.859412% of the total. This is a decrease from the previous notification, where the total number of voting rights held was 4,716,463, representing 4.162000%. The voting rights are attached to shares with ISIN code GB00BDQZGK16, and there are no voting rights through financial instruments.

Disclaimer*

UK 100

Latest directors dealings